Skip to main navigation Skip to search Skip to main content

Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants

  • Tabinda Jawaid
  • , Doaa E. Elbarougy
  • , Sravanthi Lavu
  • , Guillaume Buia
  • , Sarah R. Senum
  • , Eric Olinger
  • , Hana Yang
  • , Shannon K. McDonnell
  • , Joshua T. Bublitz
  • , Jun Ma
  • , Marie-Pierre Audrézet
  • , Charles D. Madsen
  • , Rachel S. Schauer
  • , Tracy A. Baker
  • , Adriana V. Gregory
  • , Sarah E. Orr
  • , Miguel Barroso-Gil
  • , Ruxandra Neatu
  • , Giancarlo Joli
  • , Neera K. Dahl
  • Timothy L. Kline, Valentine Gillion, Karin Dahan, Francois Jouret, Ronald D. Perrone, Theodore I. Steinman, Dorien J. M. Peters, Berenice Y. Gitomer, Terry J. Watnick, Eliecer Coto, Genomics England Research Consortium, UK Biobank, HALT PKD, DIPAK, TAME PKD, Genkyst Studies, Mayo Clinic Biobank, Regeneron Genetics Center
  • Mayo Clinic Rochester, MN
  • Université de Bretagne Occidentale
  • CHU de Brest
  • Newcastle University
  • Université catholique de Louvain
  • Vita-Salute San Raffaele University
  • Center of Human Genetics
  • University of Liege
  • Tufts Medical Center
  • Beth Israel Deaconess Medical Center
  • Leiden University
  • University of Colorado Anschutz Medical Campus
  • University of Maryland, Baltimore
  • University of Oviedo
  • Mayo Clinic Jacksonville, FL
  • Autonomous University of Barcelona
  • Charité – Universitätsmedizin Berlin
  • Leipzig University
  • Mayo Clinic College of Medicine and Science

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)

Abstract

BackgroundAutosomal dominant polycystic kidney disease (ADPKD) is a common, inherited nephropathy often resulting in kidney failure. It is genetically heterogeneous; along with the major genes, PKD1 and PKD2, at least eight others have been suggested. ALG8 pathogenic variants have been associated with autosomal dominant polycystic liver disease and implicated in ADPKD, while ALG9 has been suggested as an ADPKD gene, but details of the phenotypes and penetrance are unclear.MethodsWe screened >3900 families with cystic kidneys and/or livers using global approaches to detect ALG8 or ALG9 pathogenic variants. In addition, population cohorts with sequence data (Genomics England 100K Genomics Project, UK Biobank, and Mayo Clinic Biobank [MCBB]) were screened for ALG8/ALG9 pathogenic variants.ResultsMulticenter screening of individuals with polycystic kidney and/or liver disease identified 51 (1.3%) ALG8 (7 multiplex) and 23 (0.6%) ALG9 (5 multiplex) families - frequencies that were approximately 10× and approximately 24× greater than nonpolycystic kidney disease controls. Analysis of individuals with polycystic kidney disease phenotypes in 100K Genomics Project, UK Biobank, and MCBB identified nine ALG8 (0.39%) and nine ALG9 (0.39%) families, an enriched frequency over controls. Two individuals had PKD1 and ALG8 pathogenic changes. Eighty-nine percent of individuals with ALG8 mutations with imaging in the entire MCBB had kidney cysts (50%, >10 cysts), with greater median kidney and liver cyst numbers than controls. For ALG9, 78% had kidney cysts (27%, >10 cysts). Individuals with ALG8 mutations typically had mild cystic kidneys with limited enlargement. Liver cysts were common (71%), with enlarged livers (>2L) found in 11 of 62 patients, although surgical intervention was rare. The ALG9 kidney phenotype was also of mild cystic kidneys, but enlarged livers were rare; for both genes, CKD or kidney failure were rare.ConclusionsALG8 and ALG9 are defined as cystic kidney/liver genes but with limited penetrance for lower eGFR.
Original languageEnglish
Pages (from-to)1056-1071
Number of pages16
JournalClinical journal of the American Society of Nephrology
Volume36
Issue number6
DOIs
Publication statusPublished - 1 Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ADPKD
  • genetic diseases and development
  • nephropathy
  • polycystic kidney disease

Fingerprint

Dive into the research topics of 'Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants'. Together they form a unique fingerprint.

Cite this